B&L Seeks Preliminary Approval of $40 Million Immunomedics Settlement

Proposed settlement comes after four years of intense litigation.

Block & Leviton today filed a motion seeking preliminary approval of a $40 million settlement in the long-running securities case against Immunomedics (which has since been acquired) and its executives. Additional details about the settlement are available on the case website.

Block & Leviton is co-lead counsel with Robbins, Geller, Rudman & Dowd LLP in this litigation.

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.

January 20, 2023

More News Stories

August 23, 2023
Immunomedics, Inc. Securities Litigation Settles for $40 million

Court Highlights Block & Leviton's Hard Work, Professionalism and Detailed Advocacy

Read story
August 23, 2023
Block & Leviton to lead securities class action against Match Group, Inc.

Court notes Block & Leviton's substantial experience in securities fraud litigation.

Read story
August 23, 2023
Court Approves $25 million Lyft Settlement

Court finds recovery significant when weighed against the litigation risks in the case

Read story